Results 231 to 240 of about 2,657,787 (357)

Interferon and cell differentiation [PDF]

British Journal of Cancer, 1986
openaire   +3 more sources

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Phycocyanin enhances potential neural stem cell differentiation in iron doped chitosan hydroxyapatite scaffolds. [PDF]

Sci Rep
Maskanati M, Ahmadi M, Sabet Sarvestani F, Morowvat MH.   +3 more
europepmc   +1 more source

Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. [PDF]

, 1975
Gideon Goldstein, Margrit P. Scheid, Ulrich Hämmerling, D H Schlesinger, Hugh D. Niall, Edward A. Boyse   +5 more
openalex   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Stability of differentiation-specific and nonspecific messenger RNA in insect cells.

, 1968
F C Kafatos, J. Reich
openalex   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

A novel mesothelioma molecular classification based on malignant cell differentiation. [PDF]

Cancer Cell Int
Liu J, Liu Y, Lu Y, Zhang W, Yan J, Lu B, Yao Y, Xian S, Lyu D, Shi J, Li Y, Wu X, Bai C, Zhang J, Zhang Y.   +14 more
europepmc   +1 more source

The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies

Molecular Oncology, EarlyView.
RAS‐targeted therapies have become a clinical reality. Although promising results in patients have been achieved, there are still challenges ahead such as coping with drug resistance. Here we summarize selected RAS inhibitors targeting either individual KRAS mutant isoforms (KRASG12C, KRASG12D, KRASG12V) or exhibiting a wider inhibitory spectrum ...
Matthias Drosten, Mariano Barbacid
wiley   +1 more source

The gene regulatory landscape driving mouse gonadal supporting cell differentiation. [PDF]

Sci Adv
Stévant I, Abberbock E, Ridnik M, Weiss R, Swisa L, Futtner CR, Maatouk DM, Lovell-Badge R, Malysheva V, Gonen N.   +9 more
europepmc   +1 more source